These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33395068)

  • 21. BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice.
    Wang H; Ke M; Tian Y; Wang J; Li B; Wang Y; Dou J; Zhou C
    Eur J Pharmacol; 2013 May; 707(1-3):1-10. PubMed ID: 23541725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forsythiae Fructus Inhibits B16 Melanoma Growth Involving MAPKs/Nrf2/HO-1 Mediated Anti-Oxidation and Anti-Inflammation.
    Bao J; Ding R; Zou L; Zhang C; Wang K; Liu F; Li P; Chen M; Wan JB; Su H; Wang Y; He C
    Am J Chin Med; 2016; 44(5):1043-61. PubMed ID: 27430915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo.
    Or CR; Su HL; Lee WC; Yang SY; Ho C; Chang CC
    Oncol Rep; 2016 Dec; 36(6):3465-3471. PubMed ID: 27779705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dichloroacetate induces tumor-specific radiosensitivity in vitro but attenuates radiation-induced tumor growth delay in vivo.
    Zwicker F; Kirsner A; Peschke P; Roeder F; Debus J; Huber PE; Weber KJ
    Strahlenther Onkol; 2013 Aug; 189(8):684-92. PubMed ID: 23793865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
    Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
    Cells; 2019 May; 8(5):. PubMed ID: 31109089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y; Golan M; Tyomkin D; David A
    J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancer.
    Robey IF; Martin NK
    BMC Cancer; 2011 Jun; 11():235. PubMed ID: 21663677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clopidogrel bisulfate on B16-F10 cells and tumor development in a murine model of melanoma.
    Jantsch MH; Doleski PH; Viana AR; da Silva JLG; Passos DF; Cabral FL; Manzoni AG; Ebone RDS; Soares ABU; de Andrade CM; Schetinger MRC; Leal DBR
    Biochem Cell Biol; 2023 Oct; 101(5):443-455. PubMed ID: 37163764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.
    Su L; Zhang H; Yan C; Chen A; Meng G; Wei J; Yu D; Ding Y
    Oncotarget; 2016 Oct; 7(40):65721-65731. PubMed ID: 27582548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinamide inhibits melanoma in vitro and in vivo.
    Scatozza F; Moschella F; D'Arcangelo D; Rossi S; Tabolacci C; Giampietri C; Proietti E; Facchiano F; Facchiano A
    J Exp Clin Cancer Res; 2020 Oct; 39(1):211. PubMed ID: 33028392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
    Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
    Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model.
    Liu XP; Zhou ST; Li XY; Chen XC; Zhao X; Qian ZY; Zhou LN; Li ZY; Wang YM; Zhong Q; Yi T; Li ZY; He X; Wei YQ
    J Exp Clin Cancer Res; 2010 Jun; 29(1):76. PubMed ID: 20565783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with TiO
    Adibzadeh R; Golhin MS; Sari S; Mohammadpour H; Kheirbakhsh R; Muhammadnejad A; Amanpour S; Moosavi MA; Rahmati M
    Clin Transl Oncol; 2021 Apr; 23(4):738-749. PubMed ID: 32734535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
    Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
    Pathak RK; Marrache S; Harn DA; Dhar S
    ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
    Meng X; Du G; Ye L; Sun S; Liu Q; Wang H; Wang W; Wu Z; Tian J
    Int J Immunopathol Pharmacol; 2017 Sep; 30(3):215-226. PubMed ID: 28604143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
    Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.